Has Mitchell Bosman, MD received payments from drug or device companies?

Yes. Drug and device makers reported $7,778 in general payments to Mitchell Bosman, MD across 216 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mitchell Bosman, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mitchell Bosman, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mitchell Bosman, MD

Anesthesiology · Manchester, NHNPI 1922460070

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.9% of the total across 216 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Abbott at 57.5% of the total. Among anesthesiology clinicians in NH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,778in general payments, 2019–2025

Across 216 payments — averaging $36.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$4K
Boston Scientific$615
Medtronic$599
Nevro Corp.$403
Relievant Medsystems, Inc.$350
Saluda Medical Americas, Inc.$249
plus $1K from 13 others

What the payments were for

Travel & lodging$1672%
Food & beverage$7,61198%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	120	$4,470
Boston Scientific	26	$615
Medtronic(2 entities)	17	$599
Nevro Corp.	5	$403
Relievant Medsystems, Inc.	4	$350
Saluda Medical Americas, Inc.	3	$249
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	8	$183
AbbVie	6	$161
Nalu Medical, Inc.	4	$154
Valinor Pharma, LLC	6	$133
Painteq LLC	4	$129
Vertos Medical, Inc.	2	$74
Vertex	3	$74
Biotronik NRO, Inc.	2	$56
Redhill Biopharma Inc.	1	$28
Stryker	1	$27
SPR Therapeutics, Inc	2	$26
Si-bone, Inc.	1	$25
IBSA Pharma Inc.	1	$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

PROCLAIM$1,069
Proclaim IPG$892
Proclaim Family of SCS IPGs$311
Intracept$299
Evoke SCS$204
IonicRF Generator$198
ETERNA$188
SUPERION$150
Omnia$149
Senza Spinal Cord Stimulation System$147
INTELLIS$138

How this compares

$7,778 in reported general payments places this provider in the 95th percentile of 237 anesthesiology providers in New Hampshire.

See all anesthesiology providers in New Hampshire →

Medicare billing

Part B allowed, 2024

$492,574

Medicare patients

522

Services billed

8,453

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	26	$527
Pregabalin	27	$348
Tramadol Hcl	41	$275
Gabapentin	18	$223
Cephalexin	20	$207
Tizanidine Hcl	19	$202
Cyclobenzaprine Hcl	11	$47

Paid to pharmacies, not to this prescriber.

Other anesthesiology in Manchester

Stephen DainesiManchester$514
James CormackManchester$385
Richard SpauldingManchester$218
Elizabeth Welch MarshManchester$186
David WagnerManchester$174
Brian KlaggesNashua$48K
Alex DresslerBedford$20K
Rafael VazquezSalem$16K
Stacie DeinerLebanon$13K
Andreas TaenzerLebanon$8K

See the full list for New Hampshire →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →